scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Adrienne W Paton | Q86908184 |
James Paton | Q67088717 | ||
P2093 | author name string | J C Paton | |
A W Paton | |||
P2860 | cites work | Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction | Q72584167 |
Heterogeneity of the amino-acid sequences of Escherichia coli Shiga-like toxin type-I operons | Q72613120 | ||
Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome | Q72773667 | ||
Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys | Q73494237 | ||
Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro | Q24633154 | ||
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 | ||
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype | Q24650779 | ||
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals | Q24655713 | ||
Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli | Q27644365 | ||
Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution | Q27729840 | ||
Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome | Q33351371 | ||
Experimental verocytotoxemia in rabbits | Q33353985 | ||
Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood | Q33357114 | ||
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children | Q33359877 | ||
Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. | Q33363208 | ||
Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. | Q33364452 | ||
Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome | Q33365846 | ||
Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome | Q33369261 | ||
Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome | Q33369263 | ||
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis | Q33369842 | ||
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens | Q34642972 | ||
Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes | Q35102124 | ||
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II | Q35109009 | ||
Experimental infection of calves and adult cattle with Escherichia coli O157:H7 | Q35183891 | ||
Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods | Q35186616 | ||
Escherichia coli cytotoxins and enterotoxins | Q35367741 | ||
Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli | Q35414172 | ||
Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells | Q35440445 | ||
Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine | Q35461166 | ||
Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. | Q35480200 | ||
Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice | Q35487599 | ||
Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. | Q35499213 | ||
Characterization of the acid resistance phenotype and rpoS alleles of shiga-like toxin-producing Escherichia coli | Q35507010 | ||
Translocation of Shiga toxin across polarized intestinal cells in tissue culture | Q35512892 | ||
Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. | Q35527573 | ||
Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. | Q35529931 | ||
Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. | Q35531436 | ||
Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves | Q35546957 | ||
Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains | Q35548775 | ||
A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells | Q35549056 | ||
Shiga toxin-producing Escherichia coli isolates from cases of human disease show enhanced adherence to intestinal epithelial (Henle 407) cells | Q35555337 | ||
Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis | Q35586936 | ||
Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis | Q35620166 | ||
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality | Q35773392 | ||
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells | Q35855862 | ||
Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes | Q35966752 | ||
Identification of the Shiga toxin A-subunit residues required for holotoxin assembly | Q36124364 | ||
Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. | Q36194407 | ||
Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. | Q36265701 | ||
Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus | Q36269210 | ||
The pathogenesis of edema disease in pigs. A review | Q36303500 | ||
Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. | Q36349737 | ||
Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario | Q36503463 | ||
Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. | Q54765029 | ||
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2) | Q57563891 | ||
Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum | Q59097697 | ||
Virulence Factors in Shiga-like Toxin-Producing Escherichia coliIsolated from Humans and Cattle | Q59307538 | ||
An improved selective medium for the isolation of Escherichia coli O157 | Q67948487 | ||
Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279 | Q68090249 | ||
Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine | Q68134304 | ||
Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins | Q69251152 | ||
Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes | Q69481383 | ||
Globotetraosylceramide is recognized by the pig edema disease toxin | Q69517260 | ||
Two distinct toxins active on Vero cells from Escherichia coli O157 | Q69870583 | ||
Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes | Q70230160 | ||
In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys | Q70725571 | ||
Increased oral virulence of Escherichia coli expressing a variant Shiga-like toxin type II operon is associated with both A subunit residues Met4 and Gly102 | Q70893824 | ||
Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells | Q71071340 | ||
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli | Q71454940 | ||
Direct detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction | Q71523093 | ||
Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis - United States | Q71635703 | ||
Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C | Q71670361 | ||
Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3) | Q71785854 | ||
Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin | Q72548803 | ||
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage | Q72556343 | ||
Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157 | Q72580318 | ||
Cloning and sequencing of two new Verotoxin 2 variant genes of Escherichia coli isolated from cases of human and bovine diarrhea | Q72584149 | ||
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation | Q40147730 | ||
Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells | Q40152797 | ||
Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo | Q40157780 | ||
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. | Q40160973 | ||
Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. | Q40163784 | ||
Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis | Q40165633 | ||
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells | Q40171325 | ||
Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction | Q40174976 | ||
Hybridization of strains of Escherichia coli O157 with probes derived from the eaeA gene of enteropathogenic E. coli and the eaeA homolog from a Vero cytotoxin-producing strain of E. coli O157. | Q40176222 | ||
Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins. | Q40189117 | ||
Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction | Q40197674 | ||
Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli | Q40199619 | ||
Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II. | Q40199718 | ||
Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin | Q40200136 | ||
Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. | Q40202722 | ||
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin | Q40204465 | ||
Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis | Q40205809 | ||
Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. | Q40207879 | ||
Detection of Shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP | Q40213441 | ||
Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. | Q40268887 | ||
Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release | Q40347289 | ||
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples | Q40373934 | ||
Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. | Q40374985 | ||
Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors | Q40426704 | ||
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli | Q40426825 | ||
Effects of Escherichia coli hemolysin on endothelial cell function | Q40429035 | ||
Role of verotoxin receptors in pathogenesis | Q41052833 | ||
Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin | Q41169583 | ||
Catabolite repression of the adhesion of Vero cytotoxin-producing Escherichia coli of serogroups O157 and O111. | Q41366647 | ||
Interactions between enteropathogenic Escherichia coli and host epithelial cells. | Q41395888 | ||
An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat | Q41431617 | ||
Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues | Q41474149 | ||
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli | Q41491528 | ||
Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7 | Q41506758 | ||
Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7 | Q41506780 | ||
Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. | Q41575546 | ||
Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction | Q41895684 | ||
Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. | Q41903590 | ||
Identification of Shiga-like toxin type II producing Escherichia coli using the polymerase chain reaction and a digoxigenin labelled DNA probe | Q41906716 | ||
Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM | Q42010114 | ||
Detection of toxin genes in Escherichia coli isolated from normal dogs and dogs with diarrhea. | Q42586029 | ||
Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli | Q42653384 | ||
Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli | Q42657348 | ||
EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. | Q42658756 | ||
Sequence and analysis of the O antigen gene (rfb) cluster of Escherichia coli 0111 | Q42678007 | ||
Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs | Q42941754 | ||
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers | Q43082613 | ||
A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei | Q43500013 | ||
Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. | Q43730279 | ||
Immunization of pigs with a purified Shiga-like toxin II variant toxoid | Q43813100 | ||
Pseudomonas aeruginosa can cause false-positive identification of verotoxin (Shiga-like toxin) production by a commercial enzyme immune assay system for the detection of Shiga-like toxins (SLTs) | Q43834901 | ||
Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays | Q44188611 | ||
Studies on Escherichia coli serotype O157:H7 strains containing a 60-MDa plasmid and on 60-MDa plasmid-cured derivatives | Q44692338 | ||
Adherence of Vero cytotoxin-producing Escherichia coli of serotype O157:H7 to human epithelial cells in tissue culture: role of outer membranes as bacterial adhesins | Q44966042 | ||
Characterisation of verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy | Q45048347 | ||
Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells | Q46302212 | ||
Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami--Washington and California, 1994. | Q46322672 | ||
A low molecular weight outer-membrane protein of Escherichia coli O157:H7 associated with adherence to INT407 cells and chicken caeca | Q47327826 | ||
Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C | Q47570598 | ||
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 | ||
Characterization of an exported protease from Shiga toxin-producing Escherichia coli | Q48046218 | ||
A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. | Q48065202 | ||
Characterization of IS1203, an insertion sequence in Escherichia coli O111:H-. | Q48077176 | ||
Polymerase chain reaction amplification, cloning and sequencing of variant Escherichia coli Shiga-like toxin type II operons | Q48111671 | ||
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome | Q33371235 | ||
The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins | Q33376042 | ||
Changes in the postenteropathic form of the hemolytic uremic syndrome in children | Q33377404 | ||
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome | Q33381234 | ||
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro | Q33384145 | ||
Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations | Q33396501 | ||
Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome | Q33396504 | ||
Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects | Q33397726 | ||
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects | Q33397728 | ||
The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome | Q33398109 | ||
The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota | Q33398659 | ||
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry | Q33416142 | ||
Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome | Q33420549 | ||
The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome | Q33426330 | ||
Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections | Q33429817 | ||
The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. | Q33445781 | ||
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes | Q33449435 | ||
Vero cytotoxin-producing strains of Escherichia coli | Q33449592 | ||
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome | Q33449728 | ||
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home | Q33450098 | ||
Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). | Q33453213 | ||
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools | Q33475757 | ||
Renal histopathology in the hemolytic-uremic syndrome following shigellosis | Q33477606 | ||
Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains | Q33487998 | ||
Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources. | Q33488390 | ||
A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome | Q33489393 | ||
Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection | Q33489524 | ||
Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. | Q33489940 | ||
Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. | Q33490539 | ||
Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome | Q33490700 | ||
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome | Q33490817 | ||
Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome | Q48160670 | ||
The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin | Q48318734 | ||
Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. | Q48453154 | ||
Furin-induced cleavage and activation of Shiga toxin | Q49165095 | ||
Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. | Q49232754 | ||
Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21--Helena, Montana, 1994 | Q50142989 | ||
A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture. | Q50464277 | ||
Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes. | Q50537524 | ||
Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. | Q52010910 | ||
Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine. | Q52213815 | ||
From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. | Q53414959 | ||
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. | Q54385143 | ||
Swimming-associated haemorrhagic colitis due to Escherichia coli O157:H7 infection: evidence of prolonged contamination of a fresh water lake. | Q54560999 | ||
Variation in virulence in the gnotobiotic pig model of O157:H7 Escherichia coli strains of bovine and human origin. | Q54573641 | ||
Vero cytotoxigenic Escherichia coli infection in dairy farm families. | Q54578442 | ||
Survival rate of mice after transient colonization with Escherichia coli clones carrying variant Shiga-like toxin type II operons. | Q54587409 | ||
Diarrheal and environmental isolates of Aeromonas spp. produce a toxin similar to Shiga-like toxin 1. | Q54589032 | ||
Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. | Q54590916 | ||
The detection of verocytotoxins in bacterial cultures from human diarrhoeal samples with monoclonal antibody-based ELISAs. | Q54591520 | ||
A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. | Q54591524 | ||
Phenylalanine 30 plays an important role in receptor binding of verotoxin-1. | Q54594292 | ||
Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. | Q54598931 | ||
Specific Interaction of Escherichia coli 0157:H7-Derived Shiga-like Toxin II with Human Renal Endothelial Cells | Q54601011 | ||
An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. | Q54625206 | ||
An agar-overlay method for detection of toxins produced by Escherichia coli. | Q54630305 | ||
A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. | Q54632617 | ||
Prevalence of F107 fimbriae on Escherichia coli isolated from pigs with oedema disease or postweaning diarrhoea. | Q54632759 | ||
The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. | Q54635951 | ||
Rapid diagnosis of enterohemorrhagic Escherichia coli O157:H7 directly from fecal specimens using immunofluorescence stain. | Q54644058 | ||
Verotoxin-binding in human renal sections. | Q54644479 | ||
Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. | Q54653658 | ||
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157 | Q54671989 | ||
Polymerase chain reaction for detection of verocytotoxigenic Escherichia coli isolated from animal and food sources | Q54681358 | ||
Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content | Q54683456 | ||
Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. | Q54698259 | ||
Cytotoxin activity on Vero cells among Escherichia coli strains associated with diarrhea in cats. | Q54726602 | ||
Differentiation of genes coding for Escherichia coli verotoxin 2 and the verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction. | Q37191358 | ||
Enzyme-linked immunosorbent assay for shigella toxin. | Q37207255 | ||
Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction | Q37228063 | ||
Serotype O157:H7 Escherichia coli from bovine and meat sources | Q37235962 | ||
Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis | Q37239269 | ||
Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli | Q37608531 | ||
Pore-forming cytolysins of gram-negative bacteria | Q37750817 | ||
Structure-function analyses of Shiga toxin and the Shiga-like toxins | Q37947130 | ||
Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli | Q38289838 | ||
Investigation of Shiga-like Toxin Binding to Chemically Synthesized Oligosaccharide Sequences | Q38332110 | ||
Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. | Q38334562 | ||
ACP Broadsheet 135: January 1993. Isolation and identification methods for Escherichia coli O157 and other Vero cytotoxin producing strains | Q39608165 | ||
The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis | Q39683467 | ||
Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups | Q39821292 | ||
Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons | Q39822350 | ||
Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli | Q39822837 | ||
The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. | Q39823009 | ||
Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. | Q39823954 | ||
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. | Q39824053 | ||
Polysaccharide side chains are not required for attaching and effacing adhesion of Escherichia coli O157:H7. | Q39825714 | ||
Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. | Q39829974 | ||
Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits | Q39830255 | ||
Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB. | Q39830695 | ||
Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis | Q39841227 | ||
An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli. | Q39894763 | ||
Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. | Q40006760 | ||
Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. | Q40007074 | ||
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. | Q40007934 | ||
Detection of Escherichia coli O157:H7 by multiplex PCR. | Q40008464 | ||
Rapid Immunoassay for detection of Escherichia coli O157 directly from stool specimens. | Q40010467 | ||
Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. | Q40012425 | ||
Instability of a Shiga toxin type 2 gene in Enterobacter cloacae | Q40014069 | ||
A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. | Q33491139 | ||
Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. | Q33491633 | ||
Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects | Q33491823 | ||
Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1 | Q33492004 | ||
Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples | Q33492488 | ||
A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome | Q33493023 | ||
Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. | Q33493218 | ||
Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli | Q33493367 | ||
Sequence of a variant Shiga-like toxin type-I operon of Escherichia coli O111:H-. | Q33493707 | ||
Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns | Q33493714 | ||
Endothelial heterogeneity in Shiga toxin receptors and responses. | Q33493734 | ||
Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro | Q33493841 | ||
Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. | Q33495097 | ||
Regulation of the Shiga-like toxin II operon in Escherichia coli | Q33495149 | ||
P1 blood group antigen expression and epidemic hemolytic uremic syndrome | Q33495342 | ||
Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. | Q33496269 | ||
Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli | Q33496783 | ||
Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. | Q33496795 | ||
Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. | Q33497054 | ||
Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome | Q33497368 | ||
Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system | Q33497474 | ||
Rapid detection and isolation of shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay | Q33497548 | ||
Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture | Q33497617 | ||
Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:h7. | Q33497798 | ||
The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. | Q33498515 | ||
Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1. | Q33498518 | ||
Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections | Q33499640 | ||
Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection | Q33500346 | ||
Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. | Q33501643 | ||
Multiple determinants of verotoxin-producing Escherichia coli O157:H7 attachment-effacement. | Q33605172 | ||
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice | Q33605233 | ||
Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model | Q33608157 | ||
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model | Q33902492 | ||
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family | Q34050888 | ||
Shiga toxin: purification, structure, and function | Q34115810 | ||
Vero response to a cytotoxin of Escherichia coli | Q34177128 | ||
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model | Q34185123 | ||
Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. | Q34258393 | ||
Acid resistance in enteric bacteria | Q34522511 | ||
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. | Q34534278 | ||
Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages | Q34545284 | ||
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli | Q34633814 | ||
Verotoxin producing Escherichia coli O 157 infections associated with the consumption of yoghurt | Q36503847 | ||
Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR. | Q36519199 | ||
Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli. | Q36521591 | ||
Escherichia coli O157:H7 in microbial flora of sheep | Q36527889 | ||
Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli | Q36533106 | ||
Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains | Q36543530 | ||
Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli | Q36545688 | ||
Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances | Q36752008 | ||
Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | Q36785336 | ||
Characterization of F107 fimbriae of Escherichia coli 107/86, which causes edema disease in pigs, and nucleotide sequence of the F107 major fimbrial subunit gene, fedA | Q36945164 | ||
Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses | Q36949679 | ||
An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine | Q36957798 | ||
Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin | Q36973479 | ||
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 | Q36974749 | ||
Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives | Q36980767 | ||
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 | Q36986374 | ||
Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli | Q36992491 | ||
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells | Q36999010 | ||
In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity | Q37006892 | ||
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells | Q37016559 | ||
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli | Q37031424 | ||
Shiga and Shiga-like toxins | Q37063416 | ||
Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes | Q37067703 | ||
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli | Q37112219 | ||
Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection | Q37116299 | ||
Direct detection of Escherichia coli Shiga-like toxin genes in primary fecal cultures by polymerase chain reaction. | Q37142754 | ||
Evaluation of a technique for identification of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction and digoxigenin-labeled probes | Q37146158 | ||
DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages | Q37151311 | ||
Characterization of Escherichia coli serotype O157:H7. | Q37156215 | ||
Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay | Q37156797 | ||
Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli | Q37162735 | ||
Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor | Q37174239 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pathogenesis | Q372016 |
Escherichia coli | Q25419 | ||
diagnosis | Q16644043 | ||
P304 | page(s) | 450-479 | |
450-79 | |||
P577 | publication date | 1998-07-01 | |
P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
P1476 | title | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections | |
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections | |||
P478 | volume | 11 |
Q31060435 | 2F3 monoclonal antibody recognizes the O26 O-antigen moiety of the lipopolysaccharide of enterohemorrhagic Escherichia coli strain 4276. |
Q39543360 | 4-Aminopyrazolo[3,4-d]pyrimidine (4-APP) as a novel inhibitor of the RNA and DNA depurination induced by Shiga toxin 1 |
Q90100162 | A Multistate Outbreak of E Coli O157:H7 Infections Linked to Soy Nut Butter |
Q37687820 | A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli. |
Q33384189 | A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome |
Q30940276 | A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli |
Q35073895 | A new immunoglobulin-binding protein, EibG, is responsible for the chain-like adhesion phenotype of locus of enterocyte effacement-negative, shiga toxin-producing Escherichia coli |
Q33865231 | A prebiotic, Celmanax™, decreases Escherichia coli O157:H7 colonization of bovine cells and feed-associated cytotoxicity in vitro |
Q33427445 | A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum |
Q28681413 | A sensitive multiplex, real-time PCR assay for prospective detection of Shiga toxin-producing Escherichia coli from stool samples reveals similar incidences but variable severities of non-O157 and O157 infections in northern California |
Q40572285 | A study on association of virulence determinants of verotoxic Escherichia coli isolated from cattle calves |
Q34065066 | A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. |
Q53595113 | AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. |
Q45371109 | Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter. |
Q33426863 | Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation |
Q36865822 | Adherence of non-O157 Shiga toxin-producing Escherichia coli to bovine recto-anal junction squamous epithelial cells appears to be mediated by mechanisms distinct from those used by O157. |
Q38285023 | Adhesin-encoding genes from shiga toxin-producing Escherichia coli are more prevalent in atypical than in typical enteropathogenic E. coli. |
Q33364401 | Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome |
Q36068651 | Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition |
Q33380835 | All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection |
Q40642372 | An association of 27- and 40-kDa molecules with glycolipids that bind A-B bacterial enterotoxins to cultured cells. |
Q42947533 | An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin. |
Q43234760 | Analysis of the clonal relationship of shiga toxin-producing Escherichia coli serogroup O165:H25 isolated from cattle |
Q34493644 | Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development |
Q34198790 | Antibiotic resistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in Calcutta, India |
Q33403816 | Antibodies to intimin and Escherichia coli-secreted proteins EspA and EspB in sera of Brazilian children with hemolytic uremic syndrome and healthy controls |
Q37162021 | Antibody responses elicited in mice immunized with Bacillus subtilis vaccine strains expressing Stx2B subunit of enterohaemorragic Escherichia coli O157:H7. |
Q33363266 | Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome |
Q36014947 | Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans |
Q54333617 | Applicability of a multiplex PCR to detect O26, O45, O103, O111, O121, O145, and O157 serogroups of Escherichia coli in cattle feces. |
Q54540650 | Applicability of the draft standard method for the detection of Escherichia coli O157 in dairy products. |
Q33985914 | Application of a DNA hybridization-hydrophobic-grid membrane filter method for detection and isolation of verotoxigenic escherichia coli. |
Q83467344 | Application of a multiplex PCR assay for the detection of Shigella, Escherichia coli and Shiga toxin-producing Esch. coli in milk |
Q35271625 | Application of the modular approach to an in-house validation study of real-time PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli. |
Q42209539 | Asellus aquaticus as a potential carrier of Escherichia coli and other coliform bacteria into drinking water distribution systems. |
Q35455807 | Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm |
Q33295079 | Association of Escherichia coli O157:H7 tir polymorphisms with human infection |
Q34231661 | Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates |
Q37684413 | Attaching-effacing Escherichia coli infections in cattle. |
Q35998321 | Attaching-effacing bacteria in animals |
Q40444022 | Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7. |
Q36505929 | Behavior of different Shiga toxin-producing Escherichia coli serotypes in various experimentally contaminated raw-milk cheeses |
Q34994858 | Bile salts affect expression of Escherichia coli O157:H7 genes for virulence and iron acquisition, and promote growth under iron limiting conditions |
Q38519709 | Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro |
Q34518407 | Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections |
Q37243829 | Bovine colostral antibody against verotoxin 2 derived from Escherichia coli O157:H7: resistance to proteases and effects in beagle dogs. |
Q34512492 | Carriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157. |
Q37152220 | Cattle-level risk factors associated with fecal shedding of Shiga toxin-encoding bacteria on dairy farms, Minnesota, USA. |
Q51979382 | Cellular and tissue localization of globotriaosylceramide in Fabry disease. |
Q33396647 | Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1. |
Q50571489 | Characterisation of Escherichia coli O157 isolates from Danish cattle and human patients by genotyping and presence and variants of virulence genes. |
Q42659076 | Characterization of Isolates from an outbreak of multidrug-resistant, Shiga toxin-producing Escherichia coli O145 in the United States |
Q92752746 | Characterization of Non-O157 Escherichia coli from Cattle Faecal Samples in the North-West Province of South Africa |
Q33553290 | Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans |
Q33737322 | Characterization of Shiga toxin-producing Escherichia coli from feces of sika deer (Cervus nippon) in Japan using PCR binary typing analysis to evaluate their potential human pathogenicity |
Q33805054 | Characterization of Shiga toxin-producing Escherichia coli isolated from ground beef collected in different socioeconomic strata markets in Buenos Aires, Argentina |
Q35083745 | Characterization of Shiga toxin-producing Escherichia coli isolated from healthy pigs in China |
Q33883354 | Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells |
Q33342411 | Characterization of a novel type IV pilus locus encoded on the large plasmid of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans |
Q33368880 | Characterization of attaching and effacing Escherichia coli (AEEC) isolated from pigs and sheep |
Q54380771 | Characterization of enterohemorrhagicEscherichia coliO157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate |
Q58603455 | Characterization of the Virulent Myophage ST32 |
Q28477828 | Characterizing the Escherichia coli O157:H7 proteome including protein associations with higher order assemblies |
Q33557728 | Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides |
Q34719097 | Cladophora (Chlorophyta) spp. harbor human bacterial pathogens in nearshore water of Lake Michigan |
Q34989499 | Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles |
Q33973112 | Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype |
Q73549455 | Clinical signs, reproduction of attaching/effacing lesions, and enterocyte invasion after oral inoculation of an O118 enterohaemorrhagic Escherichia coli in neonatal calves |
Q50103711 | Clonal diversity of Shiga toxin-producing Escherichia coli O103:H2/H(-) in Germany |
Q74226147 | Clonal diversity of Shiga toxin-producing Escherichia coli O157:H7/H- in Germany--a ten-year study |
Q64228476 | Coinfection of diarrheagenic bacterial and viral pathogens in piglets of Northeast region of India |
Q54495893 | Colostrum from healthy Brazilian women inhibits adhesion and contains IgA antibodies reactive with Shiga toxin-producing Escherichia coli. |
Q24675098 | Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization |
Q35064271 | Comparative analysis of super-shedder strains of Escherichia coli O157:H7 reveals distinctive genomic features and a strongly aggregative adherent phenotype on bovine rectoanal junction squamous epithelial cells |
Q35633992 | Comparative analysis of virulence genes, genetic diversity, and phylogeny of commensal and enterotoxigenic Escherichia coli isolates from weaned pigs |
Q33206424 | Comparative proteomic analysis of extracellular proteins of enterohemorrhagic and enteropathogenic Escherichia coli strains and their ihf and ler mutants |
Q53649149 | Comparison of a Commercial Reversed Passive Latex Agglutination Assay to an Enzyme Immunoassay for the Detection of Shiga Toxin-Producing Escherichia coli |
Q40133558 | Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens |
Q54458527 | Comparison of binding and effects of Escherichia coli Shiga toxin 1 on bovine and ovine granulocytes. |
Q33404523 | Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center |
Q41693521 | Concerning Increase in Antimicrobial Resistance in Shiga Toxin-Producing Escherichia coli Isolated from Young Animals during 1980-2016. |
Q89388746 | Continuous Flow-Constructed Wetlands for the Treatment of Swine Waste Water |
Q35220329 | Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21. |
Q37954322 | Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C |
Q37512505 | Curli Temper Adherence of Escherichia coli O157:H7 to Squamous Epithelial Cells from the Bovine Recto-Anal Junction in a Strain-Dependent Manner |
Q33399069 | Cytokine production is altered in monocytes from children with hemolytic uremic syndrome |
Q33754651 | Cytotoxicity potential and genotypic characterization of Escherichia coli isolates from environmental and food sources |
Q24806294 | DNA fingerprinting of Shiga-toxin producing Escherichia coli O157 based on Multiple-Locus Variable-Number Tandem-Repeats Analysis (MLVA) |
Q34002734 | Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin |
Q40564289 | Defects in polynucleotide phosphorylase impairs virulence in Escherichia coli O157:H7. |
Q36389297 | Designer probiotics for prevention of enteric infections. |
Q50334588 | Detection and Characterization of Enteropathogenic and Shiga Toxin-Producing Escherichia coli Strains in Rattus spp. from Buenos Aires. |
Q59564902 | Detection and characterisation of Shiga toxin-producing Escherichia coli other than Escherichia coli O157:H7 in wild ruminants |
Q36158862 | Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies |
Q44803816 | Detection of genes encoding for virulence and adherence factors in Escherichia coli isolated in slaughtered Sarda breed sheep. |
Q38273983 | Detection, Virulence Gene Assessment and Antibiotic Resistance Pattern of O157 Enterohemorrhagic Escherichia coli in Tabriz, Iran |
Q47104002 | Determination of Salmonella spp., E. coli VTEC, Vibrio spp., and Norovirus GI-GII in Bivalve Molluscs Collected from Growing Natural Beds in Sardinia (Italy). |
Q92783425 | Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay |
Q58779579 | Development of MoSe₂ Nano-Urchins as a Sensing Platform for a Selective Bio-Capturing of Escherichia. coli Shiga Toxin DNA |
Q36126279 | Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit |
Q33865472 | Development of a multiplex loop-mediated isothermal amplification assay to detect shiga toxin-producing Escherichia coli in cattle |
Q33753680 | Development of a quantitative RT-PCR assay to examine the kinetics of ribosome depurination by ribosome inactivating proteins using Saccharomyces cerevisiae as a model |
Q35178767 | Diagnosis and treatment of bacterial diarrhea. |
Q64972802 | Diarrhea-associated Hemolytic Uremic Syndrome in Adults: Two Case Reports and Review of the Literature. |
Q64288421 | Diarrheagenic Escherichia coli in Costa Rican children: a 9-year retrospective study |
Q33706689 | Diarrheogenic Escherichia coli |
Q64911124 | Diarrhoeagenic Escherichia coli and Escherichia albertii in Brazil: pathotypes and serotypes over a 6-year period of surveillance. |
Q34466495 | Diarrhoeagenic Escherichia coli--an emerging problem? |
Q36915495 | Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease |
Q33931539 | Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7. |
Q40312938 | Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models |
Q33947146 | Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. |
Q33963092 | Direct detection of Shiga toxigenic Escherichia coli strains belonging to serogroups O111, O157, and O113 by multiplex PCR. |
Q42098007 | Distinct pathotypes of O113 Escherichia coli strains isolated from humans and animals in Brazil |
Q37058041 | Distribution of Intimin Subtypes amongEscherichia coliIsolates from Ruminant and Human Sources |
Q44904558 | Distribution of putative adhesins in Shiga toxin-producing Escherichia coli (STEC) strains isolated from different sources in Chile |
Q37597572 | Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli |
Q38769660 | Draft Genome Sequence of Shiga Toxin-Negative Escherichia coli O157:H7 Strain C1-057, Isolated from Feedlot Cattle |
Q38011614 | E. coli O157:H7 and other toxigenic strains: the curse of global food distribution |
Q36943434 | Early attachment sites for Shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves |
Q35073309 | Edema disease caused by a clone of Escherichia coli O147. |
Q39656157 | Efa1 influences colonization of the bovine intestine by shiga toxin-producing Escherichia coli serotypes O5 and O111. |
Q33337469 | Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells |
Q42154194 | Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model |
Q43105825 | Effect of the enrichment time and immunomagnetic separation on the detection of Shiga toxin-producing Escherichia coli O26, O103, O111, O145 and sorbitol positive O157 from artificially inoculated cattle faeces. |
Q44011714 | Efficient chemoenzymatic synthesis of globotriose and its derivatives with a recombinant alpha-(1-->4)-galactosyltransferase |
Q33346344 | Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome |
Q33364194 | Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome |
Q36044254 | Enhanced CXC Chemokine Responses of Human Colonic Epithelial Cells to Locus of Enterocyte Effacement-Negative Shiga-Toxigenic Escherichia coli |
Q82754354 | Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection |
Q33963428 | Enhanced surface colonization by Escherichia coli O157:H7 in biofilms formed by an Acinetobacter calcoaceticus isolate from meat-processing environments |
Q92874205 | Enterohaemorrhagic Escherichia coli O121:H19 acquired an extended-spectrum β-lactamase gene during the development of an outbreak in two nurseries |
Q33402961 | Enterohemorrhagic E. coli (EHEC) pathogenesis |
Q42248495 | Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization |
Q39515881 | Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. |
Q37433674 | Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB. |
Q36949959 | Epithelial and mesenchymal cells in the bovine colonic mucosa differ in their responsiveness to Escherichia coli Shiga toxin 1 |
Q36396737 | Escherichia Coli O157 H7 and Shiga-like-toxin- producing Escherichia Coli in China |
Q33385428 | Escherichia coli O157: what every internist and gastroenterologist should know |
Q33676680 | Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. |
Q36949983 | Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins |
Q24604606 | Escherichia coli Subtilase Cytotoxin |
Q33659904 | Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins Bax/Bak |
Q43216194 | Evaluation of PCR and PCR-RFLP protocols for identifying Shiga toxins |
Q40672937 | Evaluation of a real-time PCR kit for detecting Escherichia coli O157 in bovine fecal samples |
Q36845005 | Evaluation of major types of Shiga toxin 2E-producing Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for humans |
Q37420029 | Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples |
Q54551411 | Evaluation of the VTEC-Screen "Seiken" test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples. |
Q33752998 | Extended-spectrum beta-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11: a new concern |
Q40074524 | Factors related to occurrence and distribution of selected bacterial and protozoan pathogens in Pennsylvania streams |
Q33393643 | Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli. |
Q30989437 | Fate of the fecal indicator Escherichia coli in irrigation with partially treated wastewater. |
Q24806304 | First isolation of the enterohaemorrhagic Escherichia coli O145:H- from cattle in feedlot in Argentina |
Q33362487 | Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome |
Q33400286 | French cattle is not a reservoir of the highly virulent enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4. |
Q38279725 | From Farm to Table: Follow-Up of Shiga Toxin-Producing Escherichia coli Throughout the Pork Production Chain in Argentina |
Q58238550 | Gene and Antigen Markers of Shiga-toxin Producing from Michigan and Indiana River Water: Occurrence and Relation to Recreational Water Quality Criteria |
Q38314441 | Genes of Escherichia coli O157:H7 that are involved in high-pressure resistance |
Q35807170 | Genetic features differentiating bovine, food, and human isolates of shiga toxin-producing Escherichia coli O157 in The Netherlands. |
Q41971375 | Genetic heterogeneity of Shiga toxin-producing Escherichia coli strains isolated in Sao Paulo, Brazil, from 1976 through 2003, as revealed by pulsed-field gel electrophoresis |
Q36868647 | Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals |
Q39626785 | Genetic profiling of enterohemorrhagic Escherichia coli strains in relation to clonality and clinical signs of infection |
Q35098340 | Genome analysis of a novel Shiga toxin 1 (Stx1)-converting phage which is closely related to Stx2-converting phages but not to other Stx1-converting phages. |
Q33428897 | Genomic Comparison of Two O111:H- Enterohemorrhagic Escherichia coli Isolates from a Historic Hemolytic-Uremic Syndrome Outbreak in Australia |
Q34317883 | Genomic variability of O islands encoding tellurite resistance in enterohemorrhagic Escherichia coli O157:H7 isolates |
Q33489852 | Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933 |
Q33304230 | Global transcriptional response of Escherichia coli O157:H7 to growth transitions in glucose minimal medium |
Q52576392 | Glycointeractions in bacterial pathogenesis. |
Q33413183 | Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli |
Q35127924 | Hemolytic uremic syndrome in pediatric intensive care units in são paulo, Brazil |
Q33339144 | Hemolytic-uremic syndrome: microbiological aspects |
Q33715173 | Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections. |
Q73904181 | High levels of background flora inhibits growth of Escherichia coli O157:H7 in ground beef |
Q61697296 | High occurrence of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle in Rio de Janeiro State, Brazil |
Q33393970 | Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. |
Q36222964 | Identification and Characterization of Novel Compounds Blocking Shiga Toxin Expression in Escherichia coli O157:H7. |
Q39520239 | Identification and characterization of class 1 integrons among atypical enteropathogenic Escherichia coli isolated from children under 5 years of age. |
Q34132947 | Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. |
Q29040822 | Identification of Human-Pathogenic Strains of Shiga Toxin-Producing Escherichia coli from Food by a Combination of Serotyping and Molecular Typing of Shiga Toxin Genes |
Q37661384 | Identification of a New Virulent Clade in Enterohemorrhagic Escherichia coli O26:H11/H- Sequence Type 29. |
Q33345353 | Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli |
Q34643412 | Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions |
Q34933393 | Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane |
Q34663367 | Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae |
Q42704861 | Identification of enterohemorrhagic Escherichia coli O26:H- genes required for intestinal colonization in calves |
Q43534050 | Identification of putative adhesin genes in shigatoxigenic Escherichia coli isolated from different sources. |
Q36537280 | Identifying new PCR targets for pathogenic bacteria using top-down LC/MS protein discovery. |
Q33384442 | Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection |
Q33366669 | Impaired neutrophils in children with the typical form of hemolytic uremic syndrome |
Q42182415 | Improving detection of Shiga toxin-producing Escherichia coli by molecular methods by reducing the interference of free Shiga toxin-encoding bacteriophages |
Q33808158 | In Vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin |
Q41429691 | In vitro adhesion properties of Shiga toxin-producing Escherichia coli isolated from cattle, food, and humans |
Q42882320 | Inability to decarboxylate lysine as a presumptive marker to identify Shiga toxin-producing Escherichia coli strains of serogroup O111. |
Q27652696 | Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin |
Q33432541 | Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome. |
Q54330524 | Influence of Asellus aquaticus on Escherichia coli, Klebsiella pneumoniae, Campylobacter jejuni and naturally occurring heterotrophic bacteria in drinking water. |
Q40725441 | Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting. |
Q34782078 | Insertions, deletions, and single-nucleotide polymorphisms at rare restriction enzyme sites enhance discriminatory power of polymorphic amplified typing sequences, a novel strain typing system for Escherichia coli O157:H7 |
Q37222599 | Instability of toxin A subunit of AB(5) toxins in the bacterial periplasm caused by deficiency of their cognate B subunits |
Q33921062 | Interaction of ricin and Shiga toxins with ribosomes |
Q33375578 | Interactions of Shiga-like toxin with human peripheral blood monocytes |
Q33999847 | Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections |
Q35028632 | Internalization of Escherichia coli o157:h7 by bovine rectal epithelial cells |
Q33377069 | Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7 |
Q36405482 | Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli |
Q34117980 | Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops |
Q33768841 | Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli |
Q33337601 | Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS? |
Q73208404 | Isolation and characterization of verocytotoxin-producing Escherichia coli O157 from slaughter pigs and poultry |
Q41878708 | Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran |
Q35759278 | Isolation of potentially pathogenic Escherichia coli O157:H7 from the Ganges River |
Q55324511 | LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice. |
Q34391508 | Laboratory approaches to infectious diarrhea |
Q42284960 | Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7. |
Q44601698 | Large-scale synthesis of globotriose derivatives through recombinant E. coli |
Q43664413 | Lectins in fruits having gastrointestinal activity: their participation in the hemagglutinating property of Escherichia coli O157:H7. |
Q35540720 | Localization of the insertion site and pathotype determination of the locus of enterocyte effacement of shiga toxin-producing Escherichia coli strains |
Q38284007 | Long polar fimbriae of enterohemorrhagic Escherichia coli O157:H7 bind to extracellular matrix proteins. |
Q37202365 | Long-term survival of Shiga toxin-producing Escherichia coli in cattle effluents and environment: an updated review. |
Q33427581 | Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice |
Q64112311 | Metagenomic Profiling of Microbial Pathogens in the Little Bighorn River, Montana |
Q33989926 | Microarray analysis of microbial virulence factors |
Q41835634 | Mild Illness during Outbreak of Shiga Toxin-Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia |
Q35584806 | Modulation of gut physiology through enteric toxins |
Q40702323 | Molecular Profiling of Shiga Toxin-Producing Escherichia coli and Enteropathogenic E. coli Strains Isolated from French Coastal Environments |
Q33378526 | Molecular analysis of shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France |
Q33347553 | Molecular and functional analysis of Shiga toxin–induced response patterns in human vascular endothelial cells |
Q35802459 | Molecular and serotyping characterization of shiga toxogenic Escherichia coli associated with food collected from Saudi Arabia |
Q36680348 | Molecular characterization and antibiotic susceptibility pattern of caprine Shiga toxin producing-Escherichia coli (STEC) isolates from India |
Q36222398 | Molecular characterization of Escherichia coli O157:H7 recovered from meat and meat products relevant to human health in Riyadh, Saudi Arabia |
Q54222372 | Molecular characterization of Shiga-toxigenic Escherichia coli isolated from diverse sources from India by multi-locus variable number tandem repeat analysis (MLVA). |
Q41837745 | Molecular characterization of Verocytotoxigenic Escherichia coli O157:H7 isolates from Argentina by Multiple-Loci VNTR Analysis (MLVA). |
Q33330051 | Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome |
Q34261800 | Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli |
Q47143123 | Molecular characterization of locus of enterocyte effacement pathogenicity island in shigatoxic Escherichia coli isolated from human & cattle in West Bengal, India. |
Q30798461 | Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113 |
Q41873961 | Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin |
Q35805531 | Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains. |
Q48172613 | Molecular prediction of the O157:H- phenotype prevalent in Australian STEC cases improves the concordance of in silico serotyping with phenotypic motility |
Q33380705 | Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody |
Q39863740 | Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells |
Q36153028 | Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. |
Q54390221 | Multiplex PCR assay for the detection of five putative virulence genes encoded in verotoxigenic Escherichia coli plasmids. |
Q33856439 | Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxin |
Q46800667 | Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli. |
Q33987697 | Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111 |
Q40014538 | Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep. |
Q39491019 | Mutations in the csgD promoter associated with variations in curli expression in certain strains of Escherichia coli O157:H7. |
Q33338235 | Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. |
Q34006601 | Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose |
Q35840558 | Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli |
Q33960615 | Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective |
Q37435390 | Non-O157:H7 Shiga Toxin Producing Diarrhoeagenic Escherichia coli (STEC) in Southern India: A Tinderbox for Starting Epidemic |
Q54265531 | Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity. |
Q39755249 | Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin |
Q39896145 | Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity |
Q33428053 | Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7 |
Q43097019 | Novel subtilase cytotoxin produced by Shiga-toxigenic Escherichia coli induces apoptosis in vero cells via mitochondrial membrane damage |
Q47907946 | Occurrence and characteristics of enterohemorrhagic Escherichia coli O157 in calves associated with diarrhoea |
Q43683508 | Occurrence and characteristics of enterohemorrhagic Escherichia coli O26 and O111 in calves associated with diarrhea |
Q90375380 | Occurrence of Escherichia coli carrying Shiga toxin-producing genes in buffaloes on smallholdings in Bangladesh |
Q38320358 | Occurrence of diarrheagenic virulence genes and genetic diversity in Escherichia coli isolates from fecal material of various avian hosts in British Columbia, Canada |
Q42598711 | Occurrence of subtilase cytotoxin and relation with other virulence factors in verocytotoxigenic Escherichia coli isolated from food and cattle in Argentina |
Q38884698 | Occurrence, genotyping, shiga toxin genes and associated risk factors of E. coli isolated from dairy farms, handlers and milk consumers. |
Q30279200 | Optical Imaging of Paramagnetic Bead-DNA Aggregation Inhibition Allows for Low Copy Number Detection of Infectious Pathogens |
Q33412526 | Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice |
Q33335879 | Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli |
Q42581877 | Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. |
Q42957077 | Pathoadaptive mutation that mediates adherence of shiga toxin-producing Escherichia coli O111. |
Q30690828 | PathogenFinder--distinguishing friend from foe using bacterial whole genome sequence data |
Q74107479 | Pathogenic characteristics of Escherichia coli strains isolated from newborn piglets with diarrhea in Brazil |
Q28548608 | Persistence of Pathogenic and Non-Pathogenic Escherichia coli Strains in Various Tropical Agricultural Soils of India |
Q37511401 | Phage types and genotypes of shiga toxin-producing Escherichia coli O157:H7 isolates from humans and animals in spain: identification and characterization of two predominating phage types (PT2 and PT8). |
Q37127737 | Phage-mediated Shiga toxin 2 gene transfer in food and water |
Q54494278 | Phenotypic and genotypic characteristics of non-O157 Shiga toxin-producing Escherichia coli (STEC) from Swiss cattle. |
Q34801950 | Phylogenetic Clades 6 and 8 of Enterohemorrhagic Escherichia coli O157:H7 With Particular stx Subtypes are More Frequently Found in Isolates From Hemolytic Uremic Syndrome Patients Than From Asymptomatic Carriers. |
Q91963507 | Phylogenetic Diversity, Antimicrobial Susceptibility and Virulence Characteristics of Escherichia coli Isolates from Pigeon Meat |
Q35097434 | Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children |
Q39472250 | Plasmids from Shiga Toxin-Producing Escherichia coli Strains with Rare Enterohemolysin Gene (ehxA) Subtypes Reveal Pathogenicity Potential and Display a Novel Evolutionary Path |
Q35140033 | Point: Should all stools be screened for Shiga toxin-producing Escherichia coli? |
Q39625812 | Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins |
Q36288461 | Polymorphic Amplified Typing Sequences and Pulsed-Field Gel Electrophoresis Yield Comparable Results in the Strain Typing of a Diverse Set of Bovine Escherichia coli O157:H7 Isolates |
Q37712911 | Potentially pathogenic Escherichia coli can form a biofilm under conditions relevant to the food production chain |
Q50574919 | Preponderance of toxigenic Escherichia coli in stool pathogens correlates with toxin detection in accessible drinking-water sources. |
Q33725263 | Presence and characterization of shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats |
Q44676802 | Presence in bovine enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) Escherichia coli of genes encoding for putative adhesins of human EHEC strains |
Q33331011 | Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality |
Q40230539 | Prevalence and Characterization of Shiga Toxin-Producing and Enteropathogenic Escherichia coli in Shellfish-Harvesting Areas and Their Watersheds |
Q34258550 | Prevalence and characteristics of Shiga toxin-producing Escherichia coli (STEC) from cattle in Korea between 2010 and 2011. |
Q35942443 | Prevalence and characteristics of eae-positive Escherichia coli from healthy cattle in Japan |
Q54369156 | Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 in beef farms. |
Q33965946 | Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France |
Q39648688 | Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli on carcasses in commercial beef cattle processing plants. |
Q41129049 | Prevalence and distribution of the stx, stx genes in Shiga toxin producing E. coli (STEC) isolates from cattle. |
Q36897978 | Prevalence and genetic characterization of shiga toxin-producing Escherichia coli isolates from slaughtered animals in Bangladesh |
Q39894339 | Prevalence and occurrence of zoonotic bacterial pathogens in surface waters determined by quantitative PCR. |
Q34720491 | Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants |
Q36876617 | Prevalence of Escherichia coli Virulence Genes in Patients with Diarrhea and a Subpopulation of Healthy Volunteers in Madrid, Spain. |
Q54381281 | Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting Phage. |
Q35757902 | Prevalence of Verotoxin-Producing Escherichia coli (VTEC) in a survey of dairy cattle in Najaf, Iraq |
Q36395667 | Prevalence of diarrheagenic Escherichia coli virulence genes in the feces of slaughtered cattle, chickens, and pigs in Burkina Faso |
Q37263266 | Prevalence of hemolysin genes and comparison of ehxA subtype patterns in Shiga toxin-producing Escherichia coli (STEC) and non-STEC strains from clinical, food, and animal sources |
Q40643487 | Prevalence of sorbitol non-fermenting Shiga toxin-producing Escherichia coli in Black Bengal goats on smallholdings. |
Q54517016 | Prevalence of the lpfO113 gene cluster among Escherichia coli O157 isolates from different sources. |
Q40937787 | Prevalence of the stx2 gene in coliform populations from aquatic environments |
Q33592467 | Prevalence, virulence potential, and pulsed-field gel electrophoresis profiling of Shiga toxin-producing Escherichia coli strains from cattle |
Q54541586 | Primary fecal culture used as template for PCR detection of diarrheagenic E. coli virulence factors. |
Q35295605 | Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns |
Q35060348 | Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1. |
Q61697285 | Properties of Shiga toxin-producing Escherichia coli (STEC) isolates from sheep in the State of São Paulo, Brazil |
Q35946861 | Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin |
Q35947400 | Protection against Shiga-Toxigenic Escherichia coli by Non-Genetically Modified Organism Receptor Mimic Bacterial Ghosts |
Q33883465 | Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli |
Q34805497 | Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets |
Q50093767 | Putative virulence factors and clonal relationship of O174 Shiga toxin-producing Escherichia coli isolated from human, food and animal sources |
Q42780065 | Quantification and evaluation of infectivity of shiga toxin-encoding bacteriophages in beef and salad |
Q34108892 | Quantification of Shiga toxin-converting bacteriophages in wastewater and in fecal samples by real-time quantitative PCR. |
Q34452904 | Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler |
Q39463088 | Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes |
Q30726762 | Reactivity of convalescent-phase hemolytic-uremic syndrome patient sera with the megaplasmid-encoded TagA protein of Shiga toxigenic Escherichia coli O157 |
Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
Q45043220 | Rectal inoculation of sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response |
Q37274702 | Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge |
Q34491859 | Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21. |
Q40564019 | Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1 |
Q40003596 | Relationship between phylogenetic groups, genotypic clusters, and virulence gene profiles of Escherichia coli strains from diverse human and animal sources. |
Q33372623 | Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia |
Q33379972 | Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains |
Q34298378 | Retinoid levels influence enterohemorrhagic Escherichia coli infection and Shiga toxin 2 susceptibility in mice |
Q40664427 | Ribosome-inactivating proteins depurinate poly(ADP-ribosyl)ated poly(ADP-ribose) polymerase and have transforming activity for 3T3 fibroblasts |
Q92644031 | Rise of the killer plants: investigating the antimicrobial activity of Australian plants to enhance biofilter-mediated pathogen removal |
Q51747961 | Risk factors for the occurrence of Escherichia coli virulence genes eae, stx1 and stx2 in wild bird populations. |
Q34975645 | Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa |
Q36781063 | Role of TNF-α in the mechanisms responsible for preterm delivery induced by Stx2 in rats |
Q36211187 | Role of lipid rafts and flagellin in invasion of colonic epithelial cells by Shiga-toxigenic Escherichia coli O113:H21. |
Q33343448 | Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections |
Q37274911 | Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formation |
Q41878714 | Sample processing for DNA chip array-based analysis of enterohemorrhagic Escherichia coli (EHEC). |
Q37535868 | Secondary Shiga Toxin-Producing Escherichia coli Infection, Japan, 2010-2012. |
Q45071905 | Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain |
Q44182884 | Sequence of the Escherichia coli O26 O antigen gene cluster and identification of O26 specific genes |
Q33395389 | Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans |
Q54531296 | Serotypes and Shiga toxin genotypes among Escherichia coli isolated from animals and food in Argentina and Brazil. |
Q47625726 | Serotypes and virulence genes of bovine Shigatoxigenic Escherichia coli (STEC) isolated from a feedlot in Argentina |
Q54494281 | Serotypes and virulence markers of Shiga toxin-producing Escherichia coli (STEC) isolated from dairy cattle in São Paulo State, Brazil. |
Q24810190 | Serotypes, intimin variants and other virulence factors of eae positive Escherichia coli strains isolated from healthy cattle in Switzerland. Identification of a new intimin variant gene (eae-eta2). |
Q33276264 | Serotypes, virulence genes and intimin types of Shiga toxin (verocytotoxin)-producing Escherichia coli isolates from minced beef in Lugo (Spain) from 1995 through 2003. |
Q40585426 | Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-xi) |
Q39748540 | Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. |
Q35553506 | Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. |
Q34092252 | Shiga Toxin-Producing Escherichia coli |
Q42920438 | Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor |
Q33400603 | Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity |
Q35501790 | Shiga toxin 1 is more dependent on the P proteins of the ribosomal stalk for depurination activity than Shiga toxin 2 |
Q34715023 | Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells |
Q39190558 | Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cells |
Q33675845 | Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha |
Q31440029 | Shiga toxin 1: damage to DNA in vitro |
Q33963113 | Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation |
Q39792402 | Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak |
Q35003696 | Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury. |
Q24669550 | Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea |
Q30360953 | Shiga toxin 2a and Enteroaggregative Escherichia coli--a deadly combination |
Q37582841 | Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes |
Q34667008 | Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. |
Q90402100 | Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania |
Q34009274 | Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration |
Q54521743 | Shiga toxin- and enterotoxin-producing Escherichia coli isolated from subjects with bloody and nonbloody diarrhea in Bangkok, Thailand. |
Q43226570 | Shiga toxin-induced apoptosis is more efficiently inhibited by dimeric recombinant hybrid-IgG/IgA immunoglobulins than by the parental IgG monoclonal antibodies |
Q30439707 | Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. |
Q44287840 | Shiga toxin-producing Escherichia coli O100:H⁻: stx2e in drinking water contaminated by waste water in Finland |
Q30411012 | Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence |
Q42717586 | Shiga toxin-producing Escherichia coli in human, cattle, and foods. Strategies for detection and control |
Q54321748 | Shiga toxin-producing Escherichia coli isolated from bovine mastitic milk: serogroups, virulence factors, and antibiotic resistance properties. |
Q35094254 | Shiga toxin-producing Escherichia coli isolated from lettuce samples in tehran, iran. |
Q37021485 | Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization |
Q74609189 | Shiga toxins |
Q34002866 | Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells |
Q35593092 | Shiga toxins and apoptosis |
Q33404640 | Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals |
Q34009265 | Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression |
Q33370181 | Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome |
Q33330360 | Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells |
Q37075626 | Shiga toxins, and the genes encoding them, in fecal samples from native Idaho ungulates |
Q56892711 | Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library |
Q54294222 | Sorbitol non-fermenting shiga toxin-producing Escherichia coli in cattle on smallholdings. |
Q57125646 | Spatiotemporal Variability in Microbial Quality of Western US Agricultural Water Supplies: A Multistate Study |
Q28743696 | Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases |
Q42591654 | Strategies to avoid Shiga toxin effects |
Q38315562 | Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues. |
Q34102115 | Structure, biological functions and applications of the AB5 toxins |
Q28072394 | Structures and Ribosomal Interaction of Ribosome-Inactivating Proteins |
Q33973300 | Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors |
Q33330462 | Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways |
Q37402365 | Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes |
Q84203350 | Subtilase cytotoxin encoding genes are present in human, sheep and deer intimin-negative, Shiga toxin-producing Escherichia coli O128:H2 |
Q36362637 | Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-κB activation |
Q42067761 | Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1 |
Q39411384 | Subtilase cytotoxin-encoding subAB operon found exclusively among Shiga toxin-producing Escherichia coli strains |
Q21131304 | Synanthropic rodents as possible reservoirs of shigatoxigenic Escherichia coli strains |
Q94672737 | Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157 |
Q39888521 | Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli |
Q44581071 | Synthesis of galactose-containing oligosaccharides through superbeads and superbug approaches: substrate recognition along different biosynthetic pathways |
Q36901746 | Targeting ricin to the ribosome |
Q35689242 | TccP2 of O157:H7 and non-O157 enterohemorrhagic Escherichia coli (EHEC): challenging the dogma of EHEC-induced actin polymerization |
Q35220377 | The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide |
Q39759717 | The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. |
Q35127476 | The Effect of Polyphenols Isolated from Cynanchi wilfordii Radix with Anti-inflammatory, Antioxidant, and Anti-bacterial Activity |
Q55022785 | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ. |
Q38264894 | The Two-Component System CpxRA Negatively Regulates the Locus of Enterocyte Effacement of Enterohemorrhagic Escherichia coli Involving σ(32) and Lon protease |
Q54286969 | The c-di-GMP phosphodiesterase VmpA absent in Escherichia coli K12 strains affects motility and biofilm formation in the enterohemorrhagic O157:H7 serotype. |
Q33438408 | The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants |
Q38022246 | The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? |
Q37521652 | The neuroendocrine stress hormone norepinephrine augments Escherichia coli O157:H7-induced enteritis and adherence in a bovine ligated ileal loop model of infection |
Q39654565 | The nucleotide sequence of Shiga toxin (Stx) 2e-encoding phage phiP27 is not related to other Stx phage genomes, but the modular genetic structure is conserved. |
Q28770107 | The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression |
Q39648124 | The role of Tir, EspA, and NleB in the colonization of cattle by Shiga toxin producingEscherichia coliO26:H11 |
Q64237937 | The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components |
Q33381776 | The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes |
Q33415691 | Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome |
Q34172935 | Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli |
Q33397459 | Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome |
Q34326000 | Towards a pathogenic Escherichia coli detection platform using multiplex SYBR®Green Real-time PCR methods and high resolution melting analysis. |
Q64087546 | Toxins Utilize the Endoplasmic Reticulum-Associated Protein Degradation Pathway in Their Intoxication Process |
Q79298186 | Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells |
Q33504014 | Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity |
Q34922115 | Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin |
Q33380757 | Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). |
Q35689027 | Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli |
Q33600222 | Up-regulation of both intimin and eae-independent adherence of shiga toxigenic Escherichia coli O157 by ler and phenotypic impact of a naturally occurring ler mutation |
Q37322141 | Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations |
Q34430787 | Use of the espZ gene encoded in the locus of enterocyte effacement for molecular typing of shiga toxin-producing Escherichia coli |
Q38786642 | Variation in the Distribution of Putative Virulence and Colonization Factors in Shiga Toxin-Producing Escherichia coli Isolated from Different Categories of Cattle |
Q37467549 | Verocytotoxin-producing Escherichia coli (VTEC). |
Q42164073 | Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity. |
Q93006047 | Virulence Profiling and Molecular Typing of Shiga Toxin-Producing E. coli (STEC) from Human Sources in Brazil |
Q54404243 | Virulence gene and antibiotic resistance profile of Shiga-toxin-producing Escherichia coli prevalent in captive yaks (Poephagus grunniens). |
Q37336142 | Virulence gene profiles and population genetic analysis for exploration of pathogenic serogroups of Shiga toxin-producing Escherichia coli. |
Q33335591 | Virulence genotypes and serotypes of verotoxigenic Escherichia coli isolated from cattle and foods in Argentina. Importance in public health |
Q36240908 | Virulence properties and characteristics of Shiga toxin-producing Escherichia coli in São Paulo, Brazil, from 1976 through 1999 |
Q54207392 | Virulent gene profile and antibiotic susceptibility pattern of Shiga toxin-producing Escherichia coli (STEC) from cattle and camels in Maiduguri, North-Eastern Nigeria. |
Q58699815 | Whole genome shotgun sequencing revealed highly polymorphic genome regions and genes in Escherichia coli O157:H7 isolates collected from a single feedlot |
Q35069642 | Wild ungulates as disseminators of Shiga toxin-producing Escherichia coli in urban areas |
Q91818716 | Zoonotic approach to Shiga toxin-producing Escherichia coli: integrated analysis of virulence and antimicrobial resistance in ruminants and humans |
Q74167972 | [Verotoxin-producing Escherichia coli infections: study of its prevalence in children in the Auvergne region] |
Search more.